Association between WDR21A polymorphisms and airway responsiveness to inhaled corticosteroids in asthmatic patients

Pharmacogenetics and Genomics

Volumn 22, Issue 5, 2012, Pages 327-335

  Cho, Sung Hwan ^a   Park, Byung Lae ^b   Shin, Seung Woo ^a   Heo, Jeong Seok ^a   Park, Jong Sook ^a   Park, Sung Woo ^a   Jang, An Soo ^a   Chung, Il Yup ^d   Shin, Houng Doo ^b,c   Park, Choon Sik ^a,d  

^a Soonchunhyang University   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Sogang University   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

asthma; Corticosteroid; G protein subunit; G protein subunit; pharmacogenetics; single nucleotide polymorphism; WDR21A

Indexed keywords

FLUTICASONE PROPIONATE; GLUCOCORTICOID RECEPTOR; UNCLASSIFIED DRUG; WDR21A PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DNA TEMPLATE; DRUG DETERMINATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84862811279     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32834ef849     Document Type: Article

References (43)

1. Kamada AK, Szefler SJ, Martin RJ, Boushey HA, Chinchilli VM, Drazen JM, et al. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med 1996; 3:1739-1748. (Pubitemid 26187895)
2. O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. START Investigators Group. Chest 2006; 129:1478-1485. (Pubitemid 43894975)
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. Bethesda, MD: National Institutes of Health National Heart, Lung, and Blood Institute; 2002. NIH Publication No. 02-3659. J Allergy Clin Immunol 2002; 110:S141-S219.
4. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000; 162:2341-2351.
5. Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999; 130:487-495. (Pubitemid 29135801)
6. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109:410-418. (Pubitemid 34234189)
7. Jang AS, Lee JH, Park SW, Lee YM, Uh ST, Kim YH, Park CS. Factors influencing the responsiveness to inhaled glucocorticoids of patients with moderate-to-severe asthma. Chest 2005; 128:1140-1145. (Pubitemid 41324388)
8. Pignatti PF. Trends in pharmacogenomics of drugs used in the treatment of asthma. Pharmacol Res 2004; 49:343-349. (Pubitemid 38175331)
9. Bray PJ, Cotton RG. Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum Mutat 2003; 21:557-568. (Pubitemid 36667344)
10. Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004; 13:1353-1359. (Pubitemid 38961642)
11. Koper JW, Stolk RP, De Lange P, Huizenga NA, Molijn GJ, Pols HA, et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet 1997; 99:663-668. (Pubitemid 27192601)
12. Feng J, Zheng J, Bennett WP, Heston LL, Jones IR, Craddock N, Sommer SS. Five missense variants in the amino-terminal domain of the glucocorticoid receptor: no association with puerperal psychosis or schizophrenia. Am J Med Genet 2000; 96:412-417.
13. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998; 83:144-151. (Pubitemid 28498326)
14. Almawi WY, Melemedjian OK. Negative regulation of nuclear factor-kappa B activation and function by glucocorticoids. J Mol Endocrinol 2002; 28:69-78. (Pubitemid 34428757)
15. Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004; 25:45-71. (Pubitemid 38292038)
16. Tsai TC, Lee YL, Hsiao WC, Tsao YP, Chen SL. NRIP, a novel nuclear receptor interaction protein, enhances the transcriptional activity of nuclear receptors. J Biol Chem 2005; 280:20000-20009.
17. Jin J, Arias EE, Chen J, Harper JW,Walter JC. A family of diverse Cul4-Ddb1- interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell 2006; 23:709-721. (Pubitemid 44292562)
18. Lee J, Zhou P. DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol Cell 2007; 26:775-780. (Pubitemid 46921011)
19. Higa LA,Wu M, Ye T, Kobayashi R, Sun H, Zhang H. CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat Cell Biol 2006; 8:1277-1283. (Pubitemid 44660593)
20. Kino T, Tiulpakov A, Ichijo T, Cheng L, Kozasa T, Chrousos GP. G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J Cell Biol 2005; 169:885-896. (Pubitemid 41002865)
21. Livak KJ. Allelic discrimination using fluorogenic probes and the 50 nuclease assay. Genet Anal 1999; 14:143-149. (Pubitemid 29095371)
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159. (Pubitemid 17064313)
23. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117:331-341.
24. Kaplan N,Weir BS. Expected behavior of conditional linkage disequilibrium. Am J Hum Genet 1992; 51:333-343.
25. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989. (Pubitemid 32289743)
26. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74:765-769. (Pubitemid 38420107)
27. Ginalski K. Comparative modeling for protein structure prediction. Curr Opin Struct Biol 2006; 16:172-177.
28. Ginalski K, Elofsson A, Fischer D, Rychlewski L. 3D-Jury: a simple approach to improve protein structure predictions. Bioinformatics 2003; 19:1015-1018. (Pubitemid 36675823)
29. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23:2947-2948.
30. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics 2006; Chapter 5, Unit 5.6.
31. Zhang Y, Skolnick J. TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res 2005; 33:2302-2309. (Pubitemid 41439897)
32. Chen R, Tong W, Mintseris J, Li L, Weng Z. ZDOCK Predictions for the CAPRI Challenge. Proteins 2003; 52:68-73. (Pubitemid 36648852)
33. Chen Y, Stephan W. Compensatory evolution of a precursor messenger RNA secondary structure in the Drosophila melanogaster Adh gene. Proc Natl Acad Sci USA 2003; 100:11499-11504. (Pubitemid 37205965)
34. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-1200.
35. Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, Walters EH. Airway inflammation, basement, membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57:309-316. (Pubitemid 34298927)
36. Kraft M, Vianna E, Martin RJ, Leung DY. Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night. J Allergy Clin Immunol 1999; 103:66-71. (Pubitemid 29063193)
37. Gagliardo R, Chanez P, Vignola AM, Bousquet J, Vachier I, Godard P, et al. Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med 2000; 162:7-13. (Pubitemid 30469790)
38. Sher ER, Leung DY, Surs W, Kam JC, Zieg G, Kamada AK, Szefler SJ. Steroid resistant asthma: cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994; 93:33-39.
39. Willard FS, Crouch MF. Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins. Immunol Cell Biol 2000; 78:387-394. (Pubitemid 30657486)
40. Johnson LR, Scott MG, Pitcher JA. G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence. Mol Cell Biol 2004; 24:10169-10179. (Pubitemid 39507857)
41. Gobeil F, Fortier A, Zhu T, Bossolasco M, Leduc M, Grandbois M, et al. G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can J Physiol Pharmacol 2006; 84:287-297. (Pubitemid 44481092)
42. Smith MJ, Hodson ME. High-dose beclomethasone inhaler in the treatment of asthma. Lancet 1983; 1:265-269. (Pubitemid 13184280)
43. Wolfe JD, Selner JC, Mendelson LM, Hampel F Jr, Schaberg A. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study. Clin Ther 1996; 8:635-646. (Pubitemid 26323041)